PATENT CLAIM ANALYSIS

Application Number: 16130789
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "313000"]

Abstract:
Aminoquinoline compounds useful for treating chronic pain, addiction, and other conditions are provided. The aminoquinoline compound is represented by Formula (I): in which the substituents thereof are defined as set forth in the specification.

Claim (Index 17):
The method of  claim 14 , wherein R 7  is alkyl, cycloalkyl, aminoalkyl, or phenyl; R 8  is H, alkyl, cycloalkyl, aminoalkyl, or phenyl; E 1  is \u2014C(\u2550O)OR 9  or \u2014C(\u2550O)R 9 ; R 9  is H or C 1 -C 4  alkyl; and X 2  and X 3  are each independently halogen.

Metadata:
- Claim Count in Document: 128.0
- Percentile: 97.0
- Lexical Diversity: 1.13889
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15318964', '16125252', '12083110', '09171697', '14016900']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8155941783420686
- 35 USC 102 Novelty (BERT): 0.6921319913222865
- Combined Prediction Score: 0.8032479596400904
- Mean Citation Score: 452.405494
- Max Citation Score: 761.75146
- Similarity Product: 682.7951238054275

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test